Health Care & Life Sciences » Pharmaceuticals | Chunghwa Chemical Synthesis & Biotech Co. Ltd.

Chunghwa Chemical Synthesis & Biotech Co. Ltd.

Chunghwa Chemical Synthesis & Biotech Co. Ltd.
Stock Exchange Taiwan Stock Exchange
EPS
TWD3.47
Market Cap
TWD2.75 T
Shares Outstanding
77.56 M
Public Float
-

Profile

Address
No. 1 Dongxing Street
New Taipei TP 238 50
Taiwan
Employees -
Website http://www.ccsb.com.tw
Updated 07/08/2019
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the manufacture of active pharmaceutical ingredient (API). Its products include pain management for skeletal muscle pain and migraine, immunosuppressant for reducing immune activity after organ transplant, antifungal such as fluconazole,caspofungin and micafungin, oncology that act against cancers, and other APIs for lowering cholesterol and anti diabetic drugs. The company was founded on May 19, 1964 and is headquartered in New Taipei, Taiwan.

Financials

View All

Chih Ping Yang
General Manager & Director
Chih Hsien Chang
Independent Director